0004| Volume 128, SUPPLEMENT , 154967, March 2022

Non-HDL-cholesterol and atherogenicity in type 2 diabetes mellitus patients

      Background: In type 2 diabetes mellitus (DM) lipoprotein abnormalities are the main contributors resulting high atherogenic dyslipidaemia. Non-HDL-cholesterol could be used in screening patients with diabetes, especially in whom LDL-cholesterol levels may not be significantly elevated.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect